Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Sci Adv ; 5(9): eaav2045, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31579817

RESUMO

HIV persistence during combination antiretroviral therapy (cART) is the principal obstacle to cure. Mechanisms responsible for persistence remain uncertain; infections may be maintained by persistence and clonal expansion of infected cells or by ongoing replication in anatomic locations with poor antiretroviral penetration. These mechanisms require different strategies for eradication, and determining their contributions to HIV persistence is essential. We used phylogenetic approaches to investigate, at the DNA level, HIV populations in blood, lymphoid, and other infected tissues obtained at colonoscopy or autopsy in individuals who were on cART for 8 to 16 years. We found no evidence of ongoing replication or compartmentalization of HIV; we did detect clonal expansion of infected cells that were present before cART. Long-term persistence, and not ongoing replication, is primarily responsible for maintaining HIV. HIV-infected cells present when cART is initiated represent the only identifiable source of persistence and is the appropriate focus for eradication.


Assuntos
Infecções por HIV/virologia , HIV/fisiologia , Replicação Viral , Adolescente , Adulto , Fármacos Anti-HIV/farmacologia , Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Criança , Feminino , HIV/classificação , HIV/efeitos dos fármacos , HIV/genética , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Especificidade de Órgãos , Filogenia , RNA Viral , Análise de Sequência de DNA , Replicação Viral/efeitos dos fármacos , Adulto Jovem
2.
Science ; 345(6193): 179-83, 2014 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-24968937

RESUMO

The persistence of HIV-infected cells in individuals on suppressive combination antiretroviral therapy (cART) presents a major barrier for curing HIV infections. HIV integrates its DNA into many sites in the host genome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individuals on cART. About 40% of the integrations were in clonally expanded cells. Approximately 50% of the infected cells in one patient were from a single clone, and some clones persisted for many years. There were multiple independent integrations in several genes, including MKL2 and BACH2; many of these integrations were in clonally expanded cells. Our findings show that HIV integration sites can play a critical role in expansion and persistence of HIV-infected cells.


Assuntos
Fatores de Transcrição de Zíper de Leucina Básica/genética , Infecções por HIV/virologia , HIV/fisiologia , Fatores de Transcrição/genética , Integração Viral/genética , Latência Viral/genética , Antirretrovirais/uso terapêutico , Células Clonais/virologia , DNA Viral/análise , DNA Viral/genética , DNA Viral/metabolismo , Genoma Humano , HIV/genética , Infecções por HIV/tratamento farmacológico , Infecções por HIV/genética , Humanos , RNA Viral/análise , RNA Viral/genética , RNA Viral/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA